Glenmark Life Sciences manufactures and exports active pharmaceutical ingredients
Glenmark Life Sciences’ initial public offering (IPO) will open on July 27, 2021, Glenmark Pharma said in a regulatory filing to the stock exchanges. Glenmark Life Sciences…

Click here to view the original article.